Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FISV vs GSK✓SelectedUSD · GSKFISV vs GSK performance historyLatest closeAs of-6.38%11/19
Stock and ETF performance explorer

FISV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.4%
GSK return
+97.7%
Excess return
-90.3%
Maximum drawdown
-81.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.4%-1.6%-4.8%-5.9%
7D-7.9%-4.7%-3.2%-6.4%
30D+17.3%-4.7%+22.0%+19.2%
3M+8.7%-8.8%+17.5%+11.8%
6M+1.1%-4.6%+5.7%+2.3%
YTD-15.7%+1.0%-16.7%-16.7%
1Y-7.4%+6.9%-14.3%-10.2%
3Y-54.4%+52.5%-106.9%-64.0%
5Y-43.4%+40.3%-83.7%-54.5%
All+7.4%+97.7%-90.3%-27.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling